Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $8.77 $11.62 Friday, 10th May 2024 ATXS stock ended at $9.73. This is 4.33% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 7.41% from a day low at $9.45 to a day high of $10.15.
90 days $8.77 $16.90
52 weeks $4.26 $16.90

Historical Astria Therapeutics, Inc. prices

Date Open High Low Close Volume
May 10, 2024 $10.15 $10.15 $9.45 $9.73 436 766
May 09, 2024 $9.61 $10.37 $9.61 $10.17 654 090
May 08, 2024 $9.89 $9.95 $9.54 $9.57 610 737
May 07, 2024 $9.77 $10.05 $9.55 $9.98 405 690
May 06, 2024 $9.62 $9.83 $9.55 $9.77 484 269
May 03, 2024 $9.59 $9.86 $9.36 $9.55 530 902
May 02, 2024 $9.61 $9.78 $9.21 $9.35 797 047
May 01, 2024 $9.15 $9.83 $9.02 $9.50 2 710 368
Apr 30, 2024 $9.08 $9.29 $9.01 $9.18 525 290
Apr 29, 2024 $9.08 $9.45 $8.99 $9.15 616 951
Apr 26, 2024 $9.18 $9.46 $8.97 $9.00 1 099 020
Apr 25, 2024 $8.83 $9.19 $8.77 $9.17 1 309 816
Apr 24, 2024 $9.74 $9.78 $8.93 $9.00 641 506
Apr 23, 2024 $9.65 $9.97 $9.51 $9.64 743 638
Apr 22, 2024 $9.86 $10.01 $9.54 $9.80 1 526 213
Apr 19, 2024 $10.42 $10.64 $9.48 $9.75 1 238 095
Apr 18, 2024 $10.45 $10.87 $10.43 $10.54 309 647
Apr 17, 2024 $11.18 $11.29 $10.46 $10.55 543 657
Apr 16, 2024 $10.79 $11.33 $10.76 $11.10 458 817
Apr 15, 2024 $10.84 $11.12 $10.57 $10.89 441 815
Apr 12, 2024 $11.12 $11.30 $10.50 $10.81 580 428
Apr 11, 2024 $11.22 $11.62 $11.07 $11.26 741 357
Apr 10, 2024 $11.01 $11.19 $10.80 $11.17 1 107 267
Apr 09, 2024 $11.35 $11.73 $11.21 $11.49 955 589
Apr 08, 2024 $11.37 $11.64 $11.16 $11.40 575 510
Click to get the best stock tips daily for free!

About Astria Therapeutics, Inc.

Astria Therapeutics. Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage for the treatment of hereditary angioedema. The company was formerly known as Catabasis Pharmaceutical... ATXS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT